Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
暂无分享,去创建一个
Mutsushi Yamasaki | T. Nomura | F. Sato | H. Mimata | Takeo Nomura | Fuminori Sato | Hiromitsu Mimata | Mutsushi Yamasaki | Takeo Nomura
[1] P. Fraser,et al. Sensitive detection of metallothioneins-1, -2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention. , 1996, Journal of biochemical and biophysical methods.
[2] M. Burchardt,et al. Tumor hypoxia and the progression of prostate cancer , 2002, Current urology reports.
[3] C. Tohyama,et al. Metallothionein in radiation exposure: its induction and protective role. , 1999, Toxicology.
[4] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[5] P. W. Hochachka,et al. Going malignant: the hypoxia-cancer connection in the prostate. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[6] J. Lazo,et al. Enhanced apoptosis in metallothionein null cells. , 1997, Molecular pharmacology.
[7] M. Benson,et al. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells , 2003, The Prostate.
[8] J. D. Chapman,et al. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age , 2000, Cancer.
[9] J. Lazo,et al. Metallothionein null cells have increased sensitivity to anticancer drugs. , 1995, Cancer research.
[10] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[11] Cornelis J H van de Velde,et al. Prognostic Significance of Metallothionein in Human Gastrointestinal Cancer 1 , 2002 .
[12] N. Greenberg,et al. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. , 2003, The Journal of urology.
[13] A. Jayasurya,et al. Metallothioneins in human tumors and potential roles in carcinogenesis. , 2003, Mutation research.
[14] A. Chokkalingam,et al. Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.
[15] R. Franklin,et al. Inhibitory effect of zinc on human prostatic carcinoma cell growth , 1999, The Prostate.
[16] S. Theocharis,et al. Metallothionein expression in human neoplasia , 2004, Histopathology.
[17] A. Shabsigh,et al. Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids , 1999, Trends in Endocrinology & Metabolism.
[18] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[19] Kazuto Ito,et al. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. , 2003, Cancer letters.
[20] J. Isaacs,et al. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer , 1996, The Prostate.
[21] R. Franklin,et al. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells , 2002, The Prostate.
[22] S. Garrett,et al. Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC‐3 prostate cancer cells , 2002, The Prostate.
[23] A. Hanlon,et al. Hypoxic regions exist in human prostate carcinoma. , 1999, Urology.
[24] J. Lazo,et al. Metallothioneins and cell death by anticancer drugs. , 1995, Annual review of pharmacology and toxicology.
[25] J. Mohler,et al. Hypoxia increases androgen receptor activity in prostate cancer cells. , 2006, Cancer research.
[26] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] R. Chin,et al. Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. , 1994, Cancer research.
[28] Simon C Watkins,et al. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. , 1995, Cancer research.
[29] P. Baeuerle,et al. Hypoxia Induces c-fos Transcription via a Mitogen-activated Protein Kinase-dependent Pathway* , 1997, The Journal of Biological Chemistry.
[30] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[31] H Watanabe,et al. Kinetic study of tumor blood flow in prostatic cancer using power Doppler imaging. , 1999, Ultrasound in medicine & biology.
[32] A. Abdel-Mageed,et al. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. , 1997, Cancer gene therapy.
[33] N. Imura,et al. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. , 1994, Cancer research.
[34] Alexandra L Hanlon,et al. Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. , 2002, Urology.
[35] J. H. Beattie,et al. Induction, Regulation, Degradation, and Biological Significance of Mammalian Metallothioneins , 2000, Critical reviews in biochemistry and molecular biology.
[36] Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen. , 1997, Clinical and investigative medicine. Medecine clinique et experimentale.
[37] A. Shabsigh,et al. Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland , 2001, Journal of cellular biochemistry.
[38] M. Karin,et al. Regulation of human and yeast metallothionein gene transcription by heavy metal ions. , 1993, Progress in clinical and biological research.
[39] S. Garrett,et al. Metallothionein isoform 1 and 2 gene expression in the human prostate: Downregulation of MT‐1X in advanced prostate cancer , 2000, The Prostate.
[40] K. Laderoute,et al. Regulation of c-jun expression during hypoxic and low-glucose stress , 1994, Molecular and cellular biology.